Table 2.

Podoplanin expression, peripheral blood count parameters, and biomarkers of blood coagulation

Podoplanin-positive tumors (+, ++, and +++), n = 151Podoplanin-negative tumors (–), n = 62PP*
Platelet count, × 109/L 227 (186-285) 286 (241-355) <.001 .007 
Hemoglobin, g/dL 13.6 (13.0-14.5) 13.9 (13.0-14.6) .232 .384 
Leukocyte count, × 109/L 8.68 (6.30-12.15) 7.11 (5.36-10.55) .029 .289 
sP-selectin, ng/mL 36.8 (28.7-47.9) 38.8 (28.8-51.2) .513 .637 
D-dimer, μg/mL 0.85 (0.46-1.92) 0.42 (0.23-0.79) <.001 .001 
F1+F2, pmol/L 210 (154-325) 194.5 (123-260) .047 .209 
FVIII activity, % 224 (156-295) 179.5 (147-239) .006 .142 
Peak thrombin generation, nM 374 (198-552) 284 (167-493) .122 .288 
Fibrinogen, mg/dL 319 (255-381) 309 (268-381) .889 .832 
Podoplanin-positive tumors (+, ++, and +++), n = 151Podoplanin-negative tumors (–), n = 62PP*
Platelet count, × 109/L 227 (186-285) 286 (241-355) <.001 .007 
Hemoglobin, g/dL 13.6 (13.0-14.5) 13.9 (13.0-14.6) .232 .384 
Leukocyte count, × 109/L 8.68 (6.30-12.15) 7.11 (5.36-10.55) .029 .289 
sP-selectin, ng/mL 36.8 (28.7-47.9) 38.8 (28.8-51.2) .513 .637 
D-dimer, μg/mL 0.85 (0.46-1.92) 0.42 (0.23-0.79) <.001 .001 
F1+F2, pmol/L 210 (154-325) 194.5 (123-260) .047 .209 
FVIII activity, % 224 (156-295) 179.5 (147-239) .006 .142 
Peak thrombin generation, nM 374 (198-552) 284 (167-493) .122 .288 
Fibrinogen, mg/dL 319 (255-381) 309 (268-381) .889 .832 

F1+F2, prothrombin fragment 1+2; FVIII, factor VIII.

Median levels and interquartile ranges are given. Unadjusted and adjusted P values for the comparison between podoplanin-positive and -negative tumors are given.

*

Adjusted for age, sex, and tumor type (WHO grade IV tumors vs others).

Dependent variables were log-transformed to increase model fit.

or Create an Account

Close Modal
Close Modal